Polypeptides

Details for Australian Patent Application No. 2004220325 (hide)

Owner Domantis Limited

Inventors Basran, Amrik

Agent Houlihan2

Pub. Number AU-B-2004220325

PCT Pub. Number WO2004/081026

Priority PCT/GB03/002804 30.06.03 GB; 60/535,076 08.01.04 US; 60/509,613 08.10.03 US

Filing date 30 June 2004

Wipo publication date 23 September 2004

Acceptance publication date 12 May 2011

International Classifications

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/40 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against enzymes

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

Event Publications

12 January 2006 PCT application entered the National Phase

  PCT publication WO2004/081026 Priority application(s): WO2004/081026

12 May 2011 Application Accepted

  Published as AU-B-2004220325

8 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004220327-Pyridyloxymethyl and benzisoxazole azabicyclic derivatives

2004220321-Phthalazinone derivatives